Prevalence of sleep apnoea in patients with type 1 diabetes and its association with comorbidities and diabetic complications: A French nationwide prospective study
Authors' conclusion
Sleep apnoea is a significant comorbidity in patients with type 1 diabetes, especially with respect to diabetic complications. This highlights the need for sleep apnoea screening and management in these individuals.
Study context
- Population
- Adults with T1D using an insulin pump, France, July 2016–June 2020; oximetry set up by home care provider nurses
- Participants
- 769 adults
- Exposure
- Sleep apnoea severity vs no sleep apnoea
- Outcome
- Sleep apnoea prevalence (oxygen desaturation index)
Methodological detailsmulticentre, nationwide
- Multicentre
- Nationwide
Main finding
As reported in the abstract
Sleep apnoea prevalence
Observational data: associations, not effects.
Further findings
| Outcome | OR (95% CI) | P value | |
|---|---|---|---|
| Macrovascular complicationsSevere sleep apnoeavs No sleep apnoeaAdjusted for age, sex and BMI | 3.96 (1.43–11.11) | P < 0.01 | |
| DRMild-moderate sleep apnoeavs No sleep apnoeaAdjusted for age, sex and BMI | 2.09 (1.10–3.74) | P < 0.01 | |
| 0.050.21520Odds ratio (log scale) |
Factors associated with sleep apnoea (multivariate analysis)
- Age, sex, body mass index (BMI) and hypertension significantly associated with sleep apnoea
Original publication
Prevalence of sleep apnoea in patients with type 1 diabetes and its association with comorbidities and diabetic complications: A French nationwide prospective study. Diabetes Obes Metab. Published 3 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →